Bleakley Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.63M	Buy	43,322 +9,979	+30%	+$582K	0.04%	334
2025 Q4	$1.8M	Buy	33,343 +4,698	+16%	+$226K	0.03%	373
2025 Q3	$1.29M	Sell	28,645 -2,937	-9%	-$137K	0.03%	362
2025 Q2	$1.46M	Sell	31,582 -56,406	-64%	-$2.77M	0.04%	328
2025 Q1	$5.37M	Buy	87,988 +1,948	+2%	+$114K	0.17%	117
2024 Q4	$4.87M	Buy	86,040 +49,616	+136%	+$2.77M	0.15%	120
2024 Q3	$1.88M	Sell	36,424 -1,502	-4%	-$70.5K	0.06%	264
2024 Q2	$1.58M	Sell	37,926 -25,392	-40%	-$1.14M	0.05%	313
2024 Q1	$3.43M	Buy	63,318 +7,994	+14%	+$407K	0.1%	194
2023 Q4	$2.84M	Sell	55,324 -5,315	-9%	-$279K	0.09%	210
2023 Q3	$3.52M	Sell	60,639 -13,170	-18%	-$807K	0.12%	155
2023 Q2	$4.72M	Buy	73,809 +8,274	+13%	+$555K	0.15%	129
2023 Q1	$4.54M	Buy	65,535 +9,310	+17%	+$657K	0.15%	122
2022 Q4	$4.05M	Buy	+56,225	New	+$4.24M	0.14%	134